Tran, B., Lewin, J. H., O'Haire, S., Grimison, P. S., Lynam, J. F., Jones, K., Heron, O. M., Kuchel, A., Campbell, D. C., Tung, I., Marx, G. M., Namdarian, B., Kuba, M., Hitchen, N., Nair, A., Oakes, S. R., Hansen, A. R., Weickhardt, A. J., Davis, I. D., Conduit, C. (2026). Initial results from CLIMATE, a prospective cohort study assessing the clinical utility of miR-371a-3p (miR-371) as a marker of minimal residual disease (MRD) in clinical stage 1 testicular germ cell tumour (TGCT): ANZUP 1906.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.586